Hsien Ming Lee
Examiner (ID: 2434, Phone: (571)272-1863 , Office: P/2823 )
Most Active Art Unit | 2823 |
Art Unit(s) | 2823, 2814 |
Total Applications | 2398 |
Issued Applications | 2118 |
Pending Applications | 105 |
Abandoned Applications | 175 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18070088
[patent_doc_number] => 11528902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-20
[patent_title] => Method and apparatus for keeping artificially created tissues alive
[patent_app_type] => utility
[patent_app_number] => 17/339970
[patent_app_country] => US
[patent_app_date] => 2021-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 22
[patent_no_of_words] => 12393
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 625
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17339970
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/339970 | Method and apparatus for keeping artificially created tissues alive | Jun 4, 2021 | Issued |
Array
(
[id] => 19397283
[patent_doc_number] => 12071634
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-27
[patent_title] => Human iPSC-derived vascular-related and hematopoetic cells for therapies and toxicology/drug screenings
[patent_app_type] => utility
[patent_app_number] => 17/337978
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 52
[patent_no_of_words] => 57707
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17337978
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/337978 | Human iPSC-derived vascular-related and hematopoetic cells for therapies and toxicology/drug screenings | Jun 2, 2021 | Issued |
Array
(
[id] => 17243749
[patent_doc_number] => 20210363492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => EPITHELIAL CELL DIFFERENTIATION OF HUMAN MESENCHYMAL STROMAL CELLS
[patent_app_type] => utility
[patent_app_number] => 17/331257
[patent_app_country] => US
[patent_app_date] => 2021-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17331257
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/331257 | EPITHELIAL CELL DIFFERENTIATION OF HUMAN MESENCHYMAL STROMAL CELLS | May 25, 2021 | Pending |
Array
(
[id] => 18301093
[patent_doc_number] => 11622979
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-11
[patent_title] => Bone derived fibers and oxygenated wound treatments
[patent_app_type] => utility
[patent_app_number] => 17/327554
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9123
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327554
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/327554 | Bone derived fibers and oxygenated wound treatments | May 20, 2021 | Issued |
Array
(
[id] => 17022350
[patent_doc_number] => 20210246221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => CHIMERIC ANTIGEN RECEPTOR TARGETING SIALYL LEWIS A AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/233994
[patent_app_country] => US
[patent_app_date] => 2021-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233994
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/233994 | CHIMERIC ANTIGEN RECEPTOR TARGETING SIALYL LEWIS A AND USES THEREOF | Apr 18, 2021 | Pending |
Array
(
[id] => 17426845
[patent_doc_number] => 20220054553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => METHODS OF TREATING ISCHEMIA
[patent_app_type] => utility
[patent_app_number] => 17/228128
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228128
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/228128 | METHODS OF TREATING ISCHEMIA | Apr 11, 2021 | Abandoned |
Array
(
[id] => 16990227
[patent_doc_number] => 20210228647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => MESENCHYMAL STEM CELL AND USE THEREOF FOR TREATMENT OF MUSCLE INJURY AND MUSCLE-ASSOCIATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/227700
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20070
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227700
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/227700 | MESENCHYMAL STEM CELL AND USE THEREOF FOR TREATMENT OF MUSCLE INJURY AND MUSCLE-ASSOCIATED DISEASES | Apr 11, 2021 | Pending |
Array
(
[id] => 17383904
[patent_doc_number] => 20220031756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => Stem Cells for Wound Healing
[patent_app_type] => utility
[patent_app_number] => 17/222460
[patent_app_country] => US
[patent_app_date] => 2021-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17394
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17222460
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/222460 | Stem cells for wound healing | Apr 4, 2021 | Issued |
Array
(
[id] => 18871446
[patent_doc_number] => 11859235
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Sensor, detection method, reagent and kit
[patent_app_type] => utility
[patent_app_number] => 17/199380
[patent_app_country] => US
[patent_app_date] => 2021-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 7161
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199380
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/199380 | Sensor, detection method, reagent and kit | Mar 10, 2021 | Issued |
Array
(
[id] => 17097177
[patent_doc_number] => 20210284968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => METHOD FOR INDUCING ALVEOLAR EPITHELIAL PROGENITOR CELLS
[patent_app_type] => utility
[patent_app_number] => 17/194761
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12843
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194761
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/194761 | METHOD FOR INDUCING ALVEOLAR EPITHELIAL PROGENITOR CELLS | Mar 7, 2021 | Pending |
Array
(
[id] => 17037053
[patent_doc_number] => 20210254011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => METHOD OF ISOLATING MESENCHYMAL STEM CELLS FROM THE AMNIOTIC MEMBRANE OF THE UMBILICAL CORD, A MESENCHYMAL STEM CELL POPULATION ISOLATED FROM THE AMNIOTIC MEMBRANE OF THE UMBILICAL CORD AND A CELL CULTURE MEDIUM FOR ISOLATING MESENCHYMAL STEM CELLS FROM THE AMNIOTIC MEMBRANE OF THE UMBILICAL CORD
[patent_app_type] => utility
[patent_app_number] => 17/190228
[patent_app_country] => US
[patent_app_date] => 2021-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14996
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17190228
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/190228 | Method of isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord, a mesenchymal stem cell population isolated from the amniotic membrane of the umbilical cord and a cell culture medium for isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord | Mar 1, 2021 | Issued |
Array
(
[id] => 16885699
[patent_doc_number] => 20210171894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => ASEPTIC CELL PROCESSING AND PRODUCTION WITH NO CHEMICAL BIOCIDES
[patent_app_type] => utility
[patent_app_number] => 17/179468
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 331
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17179468
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/179468 | Aseptic cell processing and production with no chemical biocides | Feb 18, 2021 | Issued |
Array
(
[id] => 16885719
[patent_doc_number] => 20210171914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => HUMAN BROWN ADIPOSE DERIVED STEM CELLS AND USES
[patent_app_type] => utility
[patent_app_number] => 17/165074
[patent_app_country] => US
[patent_app_date] => 2021-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3073
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17165074
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/165074 | Human brown adipose derived stem cells and uses | Feb 1, 2021 | Issued |
Array
(
[id] => 16837993
[patent_doc_number] => 20210146005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => BIOERODIBLE MATRIX FOR TISSUE INVOLVEMENT
[patent_app_type] => utility
[patent_app_number] => 17/159132
[patent_app_country] => US
[patent_app_date] => 2021-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17159132
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/159132 | BIOERODIBLE MATRIX FOR TISSUE INVOLVEMENT | Jan 25, 2021 | Abandoned |
Array
(
[id] => 16824555
[patent_doc_number] => 20210139848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => METHODS OF PRODUCING RPE CELLS
[patent_app_type] => utility
[patent_app_number] => 17/138327
[patent_app_country] => US
[patent_app_date] => 2020-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17138327
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/138327 | Methods of producing RPE cells | Dec 29, 2020 | Issued |
Array
(
[id] => 17336434
[patent_doc_number] => 20220002765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => ACID-TOLERANT SACCHAROMYCES CEREVISIAE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/118532
[patent_app_country] => US
[patent_app_date] => 2020-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17118532
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/118532 | Acid-tolerant | Dec 9, 2020 | Issued |
Array
(
[id] => 17045162
[patent_doc_number] => 11098331
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-24
[patent_title] => Method for producing lysine by utilizing adsorption and immobilized fermentation of recombinant corynebacterium glutamicum
[patent_app_type] => utility
[patent_app_number] => 17/117788
[patent_app_country] => US
[patent_app_date] => 2020-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 6583
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17117788
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/117788 | Method for producing lysine by utilizing adsorption and immobilized fermentation of recombinant corynebacterium glutamicum | Dec 9, 2020 | Issued |
Array
(
[id] => 16720374
[patent_doc_number] => 20210087521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => CELL CULTURE SYSTEM AND CELL CULTURE METHOD
[patent_app_type] => utility
[patent_app_number] => 17/114799
[patent_app_country] => US
[patent_app_date] => 2020-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15199
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17114799
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/114799 | CELL CULTURE SYSTEM AND CELL CULTURE METHOD | Dec 7, 2020 | Pending |
Array
(
[id] => 19273273
[patent_doc_number] => 12023380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => Combined cancer therapy with immune checkpoint modulators and fermentation products by symbiotic microbiota
[patent_app_type] => utility
[patent_app_number] => 16/953026
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 18862
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16953026
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/953026 | Combined cancer therapy with immune checkpoint modulators and fermentation products by symbiotic microbiota | Nov 18, 2020 | Issued |
Array
(
[id] => 16793270
[patent_doc_number] => 20210123087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => METHOD FOR TESTING ANTIMICROBIAL ACTIVITY OF A MATERIAL
[patent_app_type] => utility
[patent_app_number] => 17/076130
[patent_app_country] => US
[patent_app_date] => 2020-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17076130
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/076130 | METHOD FOR TESTING ANTIMICROBIAL ACTIVITY OF A MATERIAL | Oct 20, 2020 | Abandoned |